An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Mayor Kate Gallego highlighted this new master's program as part of Phoenix's growing reputation as a bioscience hub. Join ...